Glenn Daniel Steele
Independent DirectorDr. Glenn Daniel Steele, Jr., M.D., Ph.D., serves as Director at Marathon Health, LLC since February 2022. He served as Director at Cleerly, Inc. since November 2021 until 2025. He serves as the Chairman of Health Advisory Board for Doctivity, Inc. from August 2022. He serves as a Special Advisor of General Atlantic Service Company, L.P. (formerly known as General Atlantic LLC) and had been a Member of Board of Advisor at InnovAccer Inc until 2025. Dr. Steele works closely with the Healthcare sector. He serves as an Executive Advisor at LRVHealth. He serves as Chairman of GSteele Health Solutions. He served as the President and Chief Executive Officer of Geisinger Health System since March 2001 until June 2015. He served as an Advisor of Health Evolution Partners. He served as the Dean of the Biological Sciences Division and the Pritzker School of Medicine and Vice President for Medical Affairs at the University of Chicago. Prior to that, he was the William V. McDermott Professor of Surgery at Harvard Medical School, President and Chief Executive Officer of Deaconess Professional Practice Group and Chairman of the Department of Surgery at New England Deaconess Hospital. Dr. Steele is the former Chairman of xG Health Solutions since January 2013 until 2018. Dr. Steele is also Honorary Chairman of the Pennsylvania March of Dimes Prematurity Campaign. He served as the Chairman of Premier, Inc. since May 2013. He served as the Chairman of the American Board of Surgery. His investigation focused on the cell biology of gastrointestinal cancer and pre-cancer and was on innovations in healthcare delivery and financing. He serves as an Independent Director of Priority Healthcare Corporation. He has been a Director of Ingenious Med, Inc. since July 21, 2015. He has been Independent Director of PTC Therapeutics, Inc. since June 15, 2015. He had been a Director of Synaptive Medical Inc. since March 30, 2017. He served as a Director of Wellcare Health Plans Inc. since October 29, 2009 until May 22, 2019. He serves as a Board Chair of City of Hope since June 1, 2020. He was a Director of City Of Hope since January 1, 2016 till May 31, 2020. He has been a Member of Advisory Board at Millennium HealthCare Inc. since February 2015. He served as a Director of Cepheid since April 2011 until November 4, 2016. He served as a Director of Premier, Inc. He served as an Independent Director of Weis Markets, Inc. from October 2009 to July 9, 2015. He serves as Vice Chair of on the Health Transformation Alliance (HTA). He serves on the following boards: Bucknell University Board of Trustees, Temple University School of Medicine Board of Visitors, The Hospital & Healthsystem Association of Pennsylvania (HAP) Board of Directors, Harvard Medical Faculty Physicians Board at Beth Israel Deaconess Medical Center, Healthcare Innovation Program (HIP) External Advisory Board (Emory University), Institute for Healthcare Optimization Advisory Board, Third Rock Ventures Business Advisory Board, Congressional Budget Office Panel of Health Advisers, Advisory Board of the Peterson Center on Healthcare Advisory Board and the Health Care Cost Containment Commission. He serves as a Trustee of American Hospital Association Inc. and was a Member of President’s Forum for Health System Leaders. He has received several awards, including the Chief Executive Officer IT Achievement Award (2006), AHA’s Grassroots Champion Award (2007), 8th Annual (2010) AHA Health Research & Education Trust Award and HFMA Board of Directors Award (2011), Solomon A. Berson Medical Alumni Achievement Award, Justin Ford Kimball Innovators Award, Gail L. Warden Healthcare Leadership Award. He has been named consecutive times to Modern Healthcare’s 50 Most Powerful Physician Executives in Healthcare, the 100 Most Powerful People in Healthcare and among Becker’s Hospital Review’s 100 Non-Profit Hospital Health System CEOs to know List (2012). A Prolific Writer, he is author or co-author of more than 481 scientific and professional articles. He is a Fellow of the American College of Surgeons and served as the President of the Society of Surgical Oncology. He received his bachelor’s degree in history and literature from Harvard College and his medical degree at the University of Colorado, where he was also a fellow of the American Cancer Society. He earned a doctorate in microbiology at Lund University in Sweden.
Positions
- Company NamePTC Therapeutics, Inc.Stock CodePTCTPositionIndependent DirectorColleagues
